fda glp-1 enforcement news today and Novo Nordisk Warned of Telehealth Compounding Takedown. What's Next? GLP-1 Pipeline Update: May 2025

Semaglutide is not a controlled substance

You have participated in a comprehensive weight management program that promotes behavioral changes, a reduced-calorie diet, and increased physical activity with continual follow-up for at least 3 months before starting on the medication

Local injection-site tolerance has been assessed in all setmelanotide toxicity studies, and the most common findings were that inflammatory injection-site reactions related mainly to the primary excipient, mPEG-DSPE, with the possible involvement of setmelanotide at high doses

HYS: Visualization, Writingoriginal draft

Mark the date you first punctured it so you know when the 28-day use window expires